Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

48

Revenue 2017

Crestor

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Crestor was produced by AstraZeneca and Shionogi.

Strong Tagrisso soothes AZ as US sales plummet

Strong Tagrisso soothes AZ as US sales plummet Sales decline 34% in the US due to low-cost copies of Crestor. ... That impact was felt particularly strongly in the US, where sales declined 34% to $1.49bn thanks largely to the launch of low-cost copies of cholesterol drug Crestor (rosuvastatin) in

2017 set to be a "defining year" for AZ

2017 set to be a The last AZ drug to fall over the 'patent cliff' - cholesterol-lowerer Crestor (rosuvastatin) - saw sales cut in half in the fourth quarter after the loss of US patent protection, with

AZ slims down again with sale of antibiotics to Pfizer

AZ slims down again with sale of antibiotics to Pfizer up cash flow in the face of a looming patent expiry for Crestor (rosuvastatin) in the US.

AZ feels Crestor sting but new products provide some relief

AZ feels Crestor sting but new products provide some relief AstraZeneca saw second quarter revenues and profits slide as competition to cholesterol drug Crestor took hold in the US. ... Overall, revenues fell 10% to $5.6bn in the second quarter, with Crestor (rosuvastatin) slipping 29% to $926m following the

AZ sells Zurampic rights to Gruenenthal for $230m

AZ sells Zurampic rights to Gruenenthal for $230m light of the loss of patent protection for blockbuster brands such as cholesterol drug Crestor (rosuvastatin) and Nexium (esomeprazole) for gastrointestinal diseases.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Genetic Digital

Genetic Digital specialises in developing digital marketing solutions for the healthcare, medical and pharmaceutical sectors. From developing a digital strategy,...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...